About Hemomed
"Em 1996, a hematologia deu origem à vocação oncológica da Hemomed Oncologia. Desde então, avançamos na busca da excelência para o tratamento de adultos, adolescentes e crianças nas áreas da oncologia e da hemato-oncologia, sempre alicerçados em tecnologias avançadas e em protocolos clínicos e terapêuticas que priorizam a humanização e o acolhimento dos pacientes."
Clinical Trials at Hemomed
During the past decade, Hemomed conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hemomed
According to Clinical.Site data, the most researched conditions in "Hemomed" are
"Crohn's Disease" (1 trials) and "Relapsed or Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Hemomed" in a lesser frequency.
Clinical Trials Intervention Types at Hemomed
Most popular intervention types in "Hemomed" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (1 trials), "Carfilzomib" (1 trials), "Dexamethasone" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hemomed
The vast majority of trials in "Hemomed" are
2 trials for "All" genders.
Clinical Trials Status at Hemomed
Currently, there are NaN active trials in "Hemomed".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Hemomed,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hemomed, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".